May 24, 2017 20:18 pm UTC| Business
NEW YORK, May 24, 2017 -- At the end of the settlement date of May 15, 2017, short interest in 2,326 Nasdaq Global MarketSM securities totaled 7,420,291,077 shares compared with 7,409,700,882 shares in 2,322 Global...
May 24, 2017 20:18 pm UTC| Business
NEW YORK, May 24, 2017 -- At the end of the settlement date of May 15, 2017, short interest in 2,326 Nasdaq Global MarketSM securities totaled 7,420,291,077 shares compared with 7,409,700,882 shares in 2,322 Global...
May 24, 2017 20:18 pm UTC| Business
NEW YORK, May 24, 2017 -- At the end of the settlement date of May 15, 2017, short interest in 2,326 Nasdaq Global MarketSM securities totaled 7,420,291,077 shares compared with 7,409,700,882 shares in 2,322 Global...
May 24, 2017 20:18 pm UTC| Business
NEW YORK, May 24, 2017 -- At the end of the settlement date of May 15, 2017, short interest in 2,326 Nasdaq Global MarketSM securities totaled 7,420,291,077 shares compared with 7,409,700,882 shares in 2,322 Global...
May 24, 2017 20:17 pm UTC| Business
TORONTO, May 24, 2017 -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI)("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of...
May 24, 2017 20:17 pm UTC| Business
TORONTO, May 24, 2017 -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI)("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of...
May 24, 2017 20:17 pm UTC| Business
TORONTO, May 24, 2017 -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI)("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of...